No Data
No Data
He Made Pfizer a Household Name. Wall Street Wants More
BioNTech Stock Dips On FDA Concerns Over Cancer Drug Trial: Retail Response Mixed
European Equities Traded in the US as American Depositary Receipts Rise Friday
BioNTech Partial Clinical Hold an 'Incremental Negative,' Says Morgan Stanley
BioNTech Shares Slip as FDA Places Partial Clinical Hold on Lung Cancer Study
BioNTech's Cancer Trial Faces FDA Hold Challenges